Philip H. Howe, PhD
Location: Hollings Cancer Center 712C
Dr. Howe is a cancer biologist and a Professor in the Department of Biochemistry and Molecular Biology. He holds the Hans and Helen Koebig Chair in Clinical Oncology and is the Associate Director of Basic Sciences at Hollings.
Dr. Howe bring scientific leadership and expertise in critical areas of research – cancer molecular biology, genetics, and signaling. He has published seminal research about cellular events, known as pathways, which transform normal cells into aggressive tumors. This new understanding of cancer development could lead to better diagnostic, preventative, and therapeutic procedures for cancer. His role includes further integrating basic science and clinical research so that discoveries made by scientists can be translated as quickly as possible into clinical trials and ultimately new therapies for patients.
Dr. Howe holds a number of prestigious grants from the National Cancer Institute (NCI) and has been continually funded for 20 years.